<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.thepeptidenewsroom.com/novo-nordisk-rebrands-glp-1s-as-lifestyle-drugs-and-patients-become-customers/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-28</news:publication_date>
      <news:title>Novo Nordisk Rebrands GLP-1s as Lifestyle Drugs, And Patients Become Customers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/doctor-sees-promise-in-peptides-but-calls-high-dose-glp-1-use-an-atomic-bomb/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-28</news:publication_date>
      <news:title>Doctor Sees Promise in Peptides, But Calls High-Dose GLP-1 Use an 'Atomic Bomb'</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.thepeptidenewsroom.com/india-canceled-its-first-peptide-party-but-the-grey-market-kept-right-on-selling/</loc>
    <news:news>
      <news:publication>
        <news:name>The Peptide Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-27</news:publication_date>
      <news:title>India Canceled Its First Peptide Party, But the Grey Market Kept Right On Selling</news:title>
    </news:news>
  </url>
</urlset>